| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| cyklofosfamid (som cyklofosfamidmonohydrat) 200 milligram/injektionsflaska, pulver till injektionsvätska | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| cyklofosfamid 20 mg/ml, infusionsvätska, lösning, flaska 200 ml | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| cyklofosfamid 20 mg/ml, infusionsvätska, lösning, flaska 100 ml | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| cyklofosfamid 20 mg/ml, infusionsvätska, lösning, flaska 50 ml | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| Cyclophosphamide 100mg/vial injection | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| Cyclophosphamide 200mg/vial injection | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| Cyclophosphamide 500mg/vial injection | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| Cyclophosphamide 1g/vial injection | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| Cyclophosphamide 2g/vial injection | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| cyklofosfamid 100 mg/flaska, pulver till injektionsvätska | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| cyklofosfamid 1 000 mg/flaska, injektionsdos | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| Cyclophosphamide 200mg/vial powder for injection | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| Cyclophosphamide 1g/vial powder for injection | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| Cyclophosphamide 500mg/vial powder for injection | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| cyklofosfamid (som cyklofosfamidmonohydrat) 2 gram/injektionsflaska, pulver till injektionsvätska | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| cyklofosfamid (som cyklofosfamidmonohydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| cyklofosfamid (som cyklofosfamidmonohydrat) 1 gram/injektionsflaska, pulver till injektionsvätska | Is a | False | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  | 
| Product containing only cyclophosphamide in parenteral dose form (medicinal product form) | Is a | True | Cyclophosphamide-containing product in parenteral dose form | Inferred relationship | Some |  |